Literature DB >> 8174756

Human kidney prolidase--purification, preincubation properties and immunological reactivity.

I Myara1, C Cosson, N Moatti, A Lemonnier.   

Abstract

1. Prolidase I (EC 3.4.13.9) was purified from human kidney to SDS-PAGE homogeneity. The molecular weights of native and denatured purified enzyme were estimated to be 115,000 and 55,000, respectively. 2. Agarose electrophoresis revealed migration in the alpha 1 globulin region, and an isoelectric point (pl) of 4.65 was estimated by both isoelectric focusing (IEF) and the titration curve method. 3. Activation by preincubation for 24 hr at 37 degrees C with 1 mM MnCl2 was maintained throughout the purification steps, using gly-pro and phe-pro dipeptides as substrates. 4. Activation in the presence of gly-pro was higher (4.5- to 11-fold) than in the presence of phe-pro (1.3- to 2.3-fold). 5. Lineweaver-Burk plot consisted of one and two lines with gly-pro and phe-pro, respectively. Km, Vmax and the Vmax/Km ratio were increased and the two lines with phe-pro were conserved after prolonged preincubation. 6. A specific polyclonal antibody was raised in rabbits against the purified enzyme and immunoreactivity was investigated between rabbit antiserum and both prolidase I from various tissues and human kidney prolidase II. 7. Prolidase I from liver, erythrocytes and plasma was immunochemically identical to renal prolidase I. The polyclonal antibody did not react with prolidase II. 8. These results indicate that a specific immunoassay might be developed to investigate prolidase I protein in plasma and tissues from patients with prolidase deficiency and hepatic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8174756     DOI: 10.1016/0020-711x(94)90147-3

Source DB:  PubMed          Journal:  Int J Biochem        ISSN: 0020-711X


  5 in total

1.  Trichomonas vaginalis metalloproteinase TvMP50 is a monomeric Aminopeptidase P-like enzyme.

Authors:  Rodrigo Arreola; José Luis Villalpando; Jonathan Puente-Rivera; Jorge Morales-Montor; Enrique Rudiño-Piñera; María Elizbeth Alvarez-Sánchez
Journal:  Mol Biotechnol       Date:  2018-08       Impact factor: 2.695

2.  The relationships among the levels of oxidative and antioxidative parameters, FEV1 and prolidase activity in COPD.

Authors:  Selami Ekin; Ahmet Arısoy; Hulya Gunbatar; Bunyamin Sertogullarindan; Aysel Sunnetcioglu; Hatice Sezen; Selvi Asker; Hanifi Yıldız
Journal:  Redox Rep       Date:  2016-02-15       Impact factor: 4.412

3.  Prolidase activity dysregulation and its correlation with oxidative-antioxidative status in chronic obstructive pulmonary disease.

Authors:  Mehmet Gencer; Nurten Aksoy; E Canan Dagli; Elmas Uzer; Sahin Aksoy; Sahbettin Selek; Hakim Celik; Hale Cakir
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

4.  Acute effect of phosphodiesterase type 5 inhibitor on serum oxidative status and prolidase activities in men with erectile dysfunction.

Authors:  Murat Savas; Ercan Yeni; Ayhan Verit; Mehmet Gulum; Nurten Aksoy; Halil Ciftci; Hakim Celik; Adem Altunkol; Halil Oncel
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

5.  Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanoma.

Authors:  Sachin Mittal; Xueqin Song; Balvinder S Vig; Gordon L Amidon
Journal:  Pharm Res       Date:  2007-03-22       Impact factor: 4.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.